| abstract |
The invention discloses the application of peginterferon and a proto-oncogene product targeting inhibitor in the synergistic treatment of tumors. Specifically, the present invention provides the use of a combination of active components, the combination of active components comprising a pegylated (PEG) interferon and a proto-oncogene product targeting inhibitor, and the combination is used to prepare a drug combination for synergistically treating tumors thing. The active ingredient combination of the present invention can effectively and synergistically inhibit the growth of tumors (especially lung cancer, gastric cancer, breast cancer, and liver cancer), and can significantly reduce the toxic and side effects, so it can be widely used in targeted therapy of tumors. |